ArticleJournal of inflammation (London, England)2026
Simplified flow cytometric quantification of human neutrophil extracellular traps (NETs).
Article in Journal of inflammation (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neutrophil extracellular traps and acute kidney injury: a narrative review.Frontiers in immunology · 2026Review
- Neutrophil extracellular traps in asthma and chronic obstructive pulmonary disease: pathogenic roles, and therapeutic opportunities.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Several cellular pathways lead to the formation of neutrophil extracellular traps (NETs), a form of cell death (NETosis), distinct from apoptotic and necrotic cell death. Surprisingly, there remains a paucity of methods enabling efficient quantification of NETosis and associated pathways. Here, we describe the development of a simple, sensitive, reliable and flexible flow cytometry assay allowing efficient detection and quantification of NETosis. For the core assay, isolated primary human neutrophils were incubated with stimulants e.g. PMA/ionomycin with or without inhibitors prior to fixing. The fixed cells were then blocked and subsequently incubated in anti-DNA/Histone 1 and anti-histone H2A antibodies for dual detection of Histone 1 and Histone H2A. Cells with were H1-DNA/H2A double fluorescent were deemed NETotic. Imaging flow cytometry was used to validate the accuracy of NETosis detection/quantification. Several key pathways of NETosis were confirmed via the use of established NET-inducers in accordance with existing established methodologies. Importantly, our novel flow cytometry-based NETosis detection assay could efficiently discriminate NETosis from established neutrophil activation, as well as apoptotic and necrotic cell death. We believe our methodology will complement existing NETosis methodologies whilst concomitantly reducing human error, subjectivity and, indeed the false positivity (attained from neutrophil activation and other cell death processes) inherent in existing methodologies. Furthermore, the simplicity and flexibility of our methodology permit additional markers and pathways of NETosis to be investigated, highlighting it as an integral research tool for both general NETosis research and the pursuit to better understand the pathogenesis of NETosis-associated diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.